Variant report

Variant	nsv822436
Chromosome Location	chr4:1396452-1402757
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr4:1400460-1400505	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr4:1400954-1401084	H1-hESC	embryonic stem cell:	n/a	n/a
3	CCNT2	chr4:1399593-1399806	K562	blood:	n/a	n/a
4	CTCF	chr4:1402346-1402474	NHEK	skin:	n/a	chr4:1402397-1402410
5	CTCF	chr4:1402320-1402487	Medullo	brain:	n/a	chr4:1402397-1402410
6	CTCF	chr4:1402303-1402540	K562	blood:	n/a	chr4:1402397-1402410
7	CTCF	chr4:1402180-1402410	SK-N-SH_RA	brain:	n/a	chr4:1402397-1402410
8	CTCF	chr4:1402340-1402490	HFF-Myc	foreskin:	n/a	chr4:1402397-1402410
9	CTCF	chr4:1402328-1402471	A549	lung:	n/a	chr4:1402397-1402410
10	CTCF	chr4:1400580-1400730	WERI-Rb-1	eye:	n/a	n/a
11	CTCF	chr4:1402360-1402510	HRE	kidney:	n/a	chr4:1402397-1402410
12	CTCF	chr4:1402340-1402490	GM12873	blood:	n/a	chr4:1402397-1402410
13	CTCF	chr4:1402333-1402437	SK-N-SH_RA	brain:	n/a	chr4:1402397-1402410
14	CTCF	chr4:1402280-1402430	BE2_C	brain:	n/a	chr4:1402397-1402410
15	CTCF	chr4:1402297-1402465	A549	lung:	n/a	chr4:1402397-1402410
16	CTCF	chr4:1402240-1402390	HBMEC	blood vessel:	n/a	n/a
17	CTCF	chr4:1402333-1402458	HepG2	liver:	n/a	chr4:1402397-1402410
18	CTCF	chr4:1402294-1402485	LNCaP	prostate:	n/a	chr4:1402397-1402410
19	CTCF	chr4:1402330-1402482	LNCaP	prostate:	n/a	chr4:1402397-1402410
20	CTCF	chr4:1402174-1402650	K562	blood:	n/a	chr4:1402397-1402410
21	CTCF	chr4:1399900-1400050	WERI-Rb-1	eye:	n/a	n/a
22	CTCF	chr4:1402320-1402470	BE2_C	brain:	n/a	chr4:1402397-1402410
23	CTCF	chr4:1402320-1402470	WERI-Rb-1	eye:	n/a	chr4:1402397-1402410
24	CTCF	chr4:1402293-1402433	SK-N-SH_RA	brain:	n/a	chr4:1402397-1402410
25	CTCF	chr4:1402200-1402350	HUVEC	blood vessel:	n/a	n/a
26	CTCF	chr4:1402300-1402450	HEK293	kidney:	n/a	chr4:1402397-1402410
27	CTCF	chr4:1402300-1402450	HMEC	breast:	n/a	chr4:1402397-1402410
28	CTCF	chr4:1397055-1397171	NHEK	skin:	n/a	n/a
29	CTCF	chr4:1402300-1402450	HRPEpiC	eye:	n/a	chr4:1402397-1402410
30	CTCF	chr4:1402380-1402530	HBMEC	blood vessel:	n/a	chr4:1402397-1402410
31	CTCF	chr4:1399840-1399990	AG04449	skin:	n/a	n/a
32	CTCF	chr4:1402387-1402441	MCF-7	breast:	n/a	chr4:1402397-1402410
33	CTCF	chr4:1402320-1402470	HepG2	liver:	n/a	chr4:1402397-1402410
34	CTCF	chr4:1402220-1402370	SK-N-SH_RA	brain:	n/a	n/a
35	CTCF	chr4:1399840-1399990	HEK293	kidney:	n/a	n/a
36	CTCF	chr4:1399902-1400002	NHEK	skin:	n/a	n/a
37	CTCF	chr4:1402179-1402584	H1-hESC	embryonic stem cell:	n/a	chr4:1402397-1402410
38	CTCF	chr4:1402340-1402490	WERI-Rb-1	eye:	n/a	chr4:1402397-1402410
39	CTCF	chr4:1402386-1402449	MCF-7	breast:	n/a	chr4:1402397-1402410
40	CTCF	chr4:1402320-1402470	K562	blood:	n/a	chr4:1402397-1402410
41	CTCF	chr4:1399854-1399974	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTCF	chr4:1402281-1402482	H1-hESC	embryonic stem cell:	n/a	chr4:1402397-1402410
43	CTCF	chr4:1402248-1402525	H1-hESC	embryonic stem cell:	n/a	chr4:1402397-1402410
44	CTCF	chr4:1402253-1402475	K562	blood:	n/a	chr4:1402397-1402410
45	CTCF	chr4:1399906-1399969	Fibrobl	skin:	n/a	n/a
46	CTCF	chr4:1402304-1402517	HepG2	liver:	n/a	chr4:1402397-1402410
47	CTCF	chr4:1402340-1402490	A549	lung:	n/a	chr4:1402397-1402410
48	CTCF	chr4:1402360-1402510	HRPEpiC	eye:	n/a	chr4:1402397-1402410
49	CTCF	chr4:1402374-1402426	GM10266	blood:	n/a	chr4:1402397-1402410
50	CTCF	chr4:1402260-1402410	HRE	kidney:	n/a	chr4:1402397-1402410

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:1402343-1402393	AoSMC	blood vessel:	n/a
2	chr4:1401409-1401459	AG04449	skin:	fetal
3	chr4:1402343-1402393	PrEC	prostate:	n/a
4	chr4:1399135-1399185	HEK293	kidney:	embryo
5	chr4:1402343-1402393	AoSMC	blood vessel:	n/a
6	chr4:1401409-1401459	AG04449	skin:	fetal
7	chr4:1402343-1402393	PrEC	prostate:	n/a
8	chr4:1399135-1399185	HEK293	kidney:	embryo
9	chr4:1401854-1401904	SK-N-MC	brain:	n/a
10	chr4:1400189-1400239	HEK293	kidney:	embryo
11	chr4:1398798-1398848	BE2_C	brain:	n/a
12	chr4:1398383-1398433	BJ	skin:	n/a
13	chr4:1397664-1397714	HepG2	liver:	n/a
14	chr4:1398599-1398649	HRCEpiC	kidney:	n/a
15	chr4:1397664-1397714	AG04450	lung:	fetal
16	chr4:1397664-1397714	HCF	heart:	n/a
17	chr4:1398139-1398189	AG09309	skin:	n/a
18	chr4:1398798-1398848	AG09319	gingival:	n/a
19	chr4:1396593-1396643	HPAEpiC	pulmonary alveolar:	n/a
20	chr4:1400189-1400239	Hela-S3	cervix:	n/a
21	chr4:1401729-1401779	PFSK-1	brain:	n/a
22	chr4:1399135-1399185	BE2_C	brain:	n/a
23	chr4:1399938-1399988	MCF-7	breast:	n/a
24	chr4:1398599-1398649	T-47D	breast:	n/a
25	chr4:1401729-1401779	SKMC	muscle:	n/a
26	chr4:1402434-1402484	SK-N-SH_RA	brain:	n/a
27	chr4:1397053-1397103	HRCEpiC	kidney:	n/a
28	chr4:1402434-1402484	GM06990	blood:	n/a
29	chr4:1400869-1400919	HL-60	blood:	n/a
30	chr4:1399235-1399285	AG04449	skin:	fetal
31	chr4:1402198-1402248	NHBE	bronchial:	n/a
32	chr4:1399938-1399988	ProgFib	skin:	n/a
33	chr4:1401409-1401459	MCF10A-Er-Src	breast:	n/a
34	chr4:1399516-1399566	Jurkat	blood:	n/a
35	chr4:1399235-1399285	IMR90	lung:	fetal
36	chr4:1401854-1401904	NH-A	brain:	n/a
37	chr4:1402434-1402484	NH-A	brain:	n/a
38	chr4:1401409-1401459	SK-N-SH	brain:	n/a
39	chr4:1402198-1402248	MCF10A-Er-Src	breast:	n/a
40	chr4:1399516-1399566	ProgFib	skin:	n/a
41	chr4:1397664-1397714	GM06990	blood:	n/a
42	chr4:1401409-1401459	PFSK-1	brain:	n/a
43	chr4:1396593-1396643	Caco-2	colon:	n/a
44	chr4:1399938-1399988	A549	lung:	n/a
45	chr4:1398798-1398848	Hela-S3	cervix:	n/a
46	chr4:1397053-1397103	HepG2	liver:	n/a
47	chr4:1400189-1400239	HRPEpiC	eye:	n/a
48	chr4:1396593-1396643	ProgFib	skin:	n/a
49	chr4:1396593-1396643	NHDF-neo	bronchial:	n/a
50	chr4:1398599-1398649	HNPCEpiC	eye:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:1240615..1242380-chr4:1393657..1396651,2	MCF-7	breast:
2	chr4:1397408..1399062-chr4:1402095..1403760,2	K562	blood:
3	chr4:1397408..1399062-chr4:1402095..1403760,2	K562	blood:
4	chr4:1391809..1396481-chr4:1400263..1404304,5	K562	blood:
5	chr4:1393172..1395524-chr4:1397007..1399469,2	K562	blood:
6	chr4:1395958..1398402-chr4:1416178..1419090,2	K562	blood:
7	chr4:1398123..1401195-chr4:1402046..1405937,3	K562	blood:
8	chr4:1391126..1393483-chr4:1395042..1398028,2	MCF-7	breast:
9	chr4:1400709..1403410-chr4:1544391..1546329,2	K562	blood:
10	chr4:1391809..1396481-chr4:1400263..1404304,5	K562	blood:

Variant related genes	Relation type
NKX1-1	TF binding region
NKX1-1	CpG island
ENSG00000235608	chromatin interactions

Extended variants
information (count: 203 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:203 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs34640463	chr4:1396455-1396456	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
2	rs111622715	chr4:1396459-1396460	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs370122620	chr4:1396460-1396461	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs546961651	chr4:1396480-1396481	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs556025302	chr4:1396509-1396510	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs150241377	chr4:1396513-1396514	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs541495585	chr4:1396516-1396517	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
8	rs560770519	chr4:1396524-1396525	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
9	rs113245383	chr4:1396591-1396592	Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
10	rs573224752	chr4:1396625-1396626	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs372567726	chr4:1396665-1396666	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs540479121	chr4:1396968-1396969	Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs565148641	chr4:1397021-1397022	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs532639143	chr4:1397050-1397051	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs551154717	chr4:1397086-1397087	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs562871770	chr4:1397112-1397113	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs530192076	chr4:1397137-1397138	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs548615648	chr4:1397151-1397152	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs566842549	chr4:1397191-1397192	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs375927221	chr4:1397230-1397231	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs534081787	chr4:1397240-1397241	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs370536650	chr4:1397254-1397255	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs552459341	chr4:1397275-1397276	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs11945310	chr4:1397297-1397298	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs537696025	chr4:1397300-1397301	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs556308688	chr4:1397350-1397351	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs200249698	chr4:1397361-1397362	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs568079039	chr4:1397406-1397407	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs535150942	chr4:1397412-1397413	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs553356348	chr4:1397421-1397422	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs368492263	chr4:1397468-1397469	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs563130808	chr4:1397485-1397486	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs571669278	chr4:1397544-1397545	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs532356178	chr4:1397574-1397575	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs371285886	chr4:1397599-1397600	Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs13133264	chr4:1397611-1397612	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs544510806	chr4:1397664-1397665	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs563062113	chr4:1397688-1397689	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs188035909	chr4:1397705-1397706	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs542295110	chr4:1397724-1397725	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs112951682	chr4:1397732-1397733	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs376819936	chr4:1397755-1397756	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs527725749	chr4:1397781-1397782	ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs368893977	chr4:1397852-1397853	Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs546707485	chr4:1397855-1397856	Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs371493143	chr4:1397860-1397861	Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs531599100	chr4:1397871-1397872	Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs138907888	chr4:1397928-1397929	Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs568202156	chr4:1398023-1398024	ZNF genes & repeats Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
50	rs565803099	chr4:1398051-1398052	ZNF genes & repeats Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Wolf-Hirschhorn syndrome	21549014	CNVD
Breast cancer	21806811	CNVD
Wolf-Hirschhorn syndrome	22283845	CNVD
Wolf-Hirschhorn syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Wolf-Hirschhorn syndrome	22470819	CNVD
Wolf-Hirschhorn syndrome	18541967	CNVD
sporadic birth defects	19047251	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Retinitis pigmentosa	18421352	CNVD
Wolf-Hirschhorn syndrome	19259404	CNVD
Bladder cancer	19242612	CNVD
Breast cancer	19242612	CNVD
Congenital anomalies of the kidney and urinary tract	19242612	CNVD
abnormal development	18461090	CNVD
Olfactory neuroblastoma	18408657	CNVD
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	17142309	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	20932292	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:252 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:1391200-1396600	Weak transcription	Right Atrium	heart
2	chr4:1393200-1397000	Weak transcription	Gastric	stomach
3	chr4:1394800-1397400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
4	chr4:1395400-1396800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
5	chr4:1395600-1396600	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
6	chr4:1395600-1398000	Bivalent Enhancer	Esophagus	oesophagus
7	chr4:1395800-1397400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
8	chr4:1395800-1397400	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
9	chr4:1395800-1399200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr4:1395800-1399400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
11	chr4:1396000-1396600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
12	chr4:1396000-1396600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
13	chr4:1396000-1396600	Bivalent Enhancer	Fetal Brain Male	brain
14	chr4:1396000-1397000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
15	chr4:1396000-1397200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
16	chr4:1396000-1397400	Bivalent Enhancer	Lung	lung
17	chr4:1396200-1396600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
18	chr4:1396200-1396600	Bivalent Enhancer	Ovary	ovary
19	chr4:1396200-1397000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
20	chr4:1396200-1397200	Enhancers	Primary B cells from cord blood	blood
21	chr4:1396200-1397200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
22	chr4:1396200-1397400	Bivalent Enhancer	Liver	Liver
23	chr4:1396200-1397400	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
24	chr4:1396200-1397600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
25	chr4:1396200-1397600	Enhancers	Primary T helper naive cells fromperipheralblood	blood
26	chr4:1396200-1398000	Bivalent Enhancer	Adipose Nuclei	Adipose
27	chr4:1396200-1400800	Enhancers	Pancreas	Pancrea
28	chr4:1396400-1396600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr4:1396400-1396600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr4:1396400-1396600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr4:1396400-1396600	Bivalent Enhancer	Fetal Intestine Small	intestine
32	chr4:1396400-1396600	Flanking Bivalent TSS/Enh	Right Ventricle	heart
33	chr4:1396400-1396600	Bivalent Enhancer	Stomach Mucosa	stomach
34	chr4:1396400-1397200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr4:1396400-1397400	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
36	chr4:1396400-1397400	Bivalent Enhancer	Spleen	Spleen
37	chr4:1396400-1397600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
38	chr4:1396400-1397800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
39	chr4:1396400-1398200	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
40	chr4:1396600-1396800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
41	chr4:1396600-1396800	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
42	chr4:1396600-1396800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
43	chr4:1396600-1396800	Bivalent Enhancer	Brain Germinal Matrix	brain
44	chr4:1396600-1396800	Bivalent/Poised TSS	Fetal Brain Female	brain
45	chr4:1396600-1397000	Flanking Bivalent TSS/Enh	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr4:1396600-1397000	Bivalent Enhancer	Right Ventricle	heart
47	chr4:1396600-1397200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
48	chr4:1396600-1397400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
49	chr4:1396600-1397800	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
50	chr4:1396800-1397000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links